Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of SR-0379 in patients with cutaneous ulcers
jRCT2080223939Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jun 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of SR-0379 in decubitus ulcer, diabetic foot ulcer (DFU) and Cutaneous ulcer (2 arms), sponsored by Shionogi & Co., Ltd. Started Jun 2018; status: completed.
02
Drugs
SR-0379
03
Conditions
decubitus ulcerdiabetic foot ulcer (DFU)Cutaneous ulcer
Beyond the preview
Go deeper on jRCT2080223939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223939.